Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The measurement of disability

D V Sheehan1, K Harnett-Sheehan, B A Raj

  • 1University of South Florida, Institute for Research in Psychiatry, Tampa 33613, USA.

International Clinical Psychopharmacology
|June 1, 1996
PubMed
Summary

Measuring functional impairment alongside psychiatric symptoms is crucial for treatment outcomes. The new Discretized Analog Disability Scale (DISS) offers a sensitive, brief, and cost-effective tool for assessing disability in psychiatric patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessment of Anxiety in Clinical Trials with Depressed Patients Using the Hamilton Depression Rating Scale.

Psychopharmacology bulletin·2016
Same author

Characteristics of responders and non-responders to risperidone monotherapy or placebo in co-occurring bipolar disorder and anxiety disorder.

European psychiatry : the journal of the Association of European Psychiatrists·2011
Same author

The speed of onset of action of alprazolam-XR compared to alprazolam-CT in panic disorder.

Psychopharmacology bulletin·2007
Same author

Nicotinic acetylcholine receptors as targets for antidepressants.

Molecular psychiatry·2002
Same author

Have drug companies hyped social anxiety disorder to increase sales. No: Efforts to relieve human suffering deserve rewards.

The Western journal of medicine·2001
Same author

Attaining remission in generalized anxiety disorder: venlafaxine extended release comparative data.

The Journal of clinical psychiatry·2001

Area of Science:

  • Psychiatry and Mental Health Assessment
  • Clinical Psychology
  • Psychometric Instrument Development

Background:

  • Psychiatric treatment outcome assessment requires evaluating both symptoms and functional impairment.
  • Current disability measures in psychiatry are often lengthy and resource-intensive.
  • A need exists for brief, sensitive, and cost-effective disability assessment tools in psychiatric care.

Purpose of the Study:

  • To introduce and evaluate the Discretized Analog Disability Scale (DISS) as a novel measure of functional impairment.
  • To assess the sensitivity of the DISS in detecting changes related to psychiatric treatment.

Main Methods:

  • Development of the Discretized Analog Disability Scale (DISS).
  • The DISS utilizes visual-spatial, numeric, and verbal anchors.

Related Experiment Videos

  • Assessment of disability across work, social life, and family life domains.

    • Main Results:

    • The DISS demonstrated high sensitivity to change in drug treatment studies.
    • The scale effectively measures disability across key life domains.

    Conclusions:

    • The Discretized Analog Disability Scale (DISS) is a valuable tool for assessing functional impairment in psychiatric disorders.
    • The DISS provides a sensitive, brief, and cost-effective method for tracking treatment outcomes in psychiatry.